查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1182035

猴痘疫苗和治疗全球市场研究与预测：副产品（疫苗、药物、疫苗免疫球蛋白）、性别、给药途径、最终用户、区域分析，2022-2029 年

Global Monkeypox Vaccine and Treatment Market Size study & Forecast, by Product (Vaccine, Drugs, Vaccinia Immune Globulin ) by Gender, by Route of Administration, by End Use and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球猴痘疫苗和治疗药物市场价值约为 7834 万美元，预计在 2022-2029 年预测期内将增长 10.2% 以上。

猴痘病毒是痘病毒科正痘病毒属的成员，是猴痘的病原体。消灭天花运动中采用的猴痘疫苗也有预防作用。猴痘疫苗和治疗市场正在扩大，原因包括猴痘感染率不断上升以及政府为防止猴痘爆发而付出的巨大努力。然而，与疫苗和治疗相关的副作用可能会阻碍市场增长。

例如，根据美国疾病控制与预防中心的信息，截至2022年8月9日，全球共有31800例猴痘确诊病例，其中31425例发生在从未报告过猴痘的国家。据估计，同时，过去有375个国家被证实感染了猴痘。此外，根据《New England Journal of Medicine》的报导，在 2022 年 4 月至 2022 年 6 月期间，男男性行为者和 LGBT 群体占全球 16 个国家猴痘病例的 98%。因此，全球范围内猴痘病流行率的上升促进了市场的增长。此外，疫苗开发技术的不断进步以及政府对研究和活动的积极主动性正在创造市场的利润丰厚的增长。然而，在整个 2022-2029 年的预测期内，猴痘疫苗和治疗的副作用将抑制市场增长。

全球猴痘疫苗和治疗市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。在这些地区中，北美将在 2021 年占据最高份额，原因是疾病流行率上升和政府加大研发投入等因素将为市场提供有利可图的增长。据预测，由于沙门氏菌感染数量增加和疫苗研发增加等因素，亚太地区预计将呈现最快的市场增长速度。

本研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。该报告旨在包括被调查国家工业的定性和定量方面。

它还提供了有关关键方面的详细信息，例如将定义市场未来增长的驱动因素和挑战。此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

目录

第一章执行摘要

  • 市场快照
  • 2019-2029 年全球市场和细分市场的估计和预测
    • 2019-2029 年按地区分列的猴痘疫苗和治疗药物市场
    • 2019-2029 年按产品分列的猴痘疫苗和治疗药物市场
    • 猴痘疫苗和治疗市场：性别歧视，2019-2029
    • 2019-2029 年按给药途径划分的猴痘疫苗和治疗市场
    • 猴痘疫苗和治疗市场最终用途，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第二章猴痘疫苗和治疗药物全球市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 产业进化
  • 调查目标年份
  • 货币兑换率

3 全球猴痘疫苗和治疗市场动态

  • 猴痘疫苗和治疗药物市场影响分析 (2019-2029)
    • 市场驱动力
      • 猴痘的发病率和流行率增加
      • 政府努力抗击猴痘疫情
    • 市场挑战
      • 与疫苗和治疗相关的副作用
    • 市场机会
      • 疫苗开发活动的进展

第四章猴痘疫苗和治疗的全球市场，行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争
  • 波特五力模型的未来方法（2019-2029）
  • PEST分析
    • 政治的
    • 经济的
    • 社会的
    • 技术的
  • 招商引资模式
  • 分析师结论/建议
  • 顶级投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的整体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

6 全球猴痘疫苗和疗法市场，按产品分类

  • 市场快照
  • 猴痘疫苗和疗法的全球市场：按产品分类，性能潜力分析
  • 2019-2029 年全球猴痘疫苗和疗法市场、按产品估计和预测
  • 猴痘疫苗和治疗市场，细分分析
    • 疫苗接种
    • 药品
    • 牛痘免疫球蛋白 (VIG)

第 7 章：猴痘疫苗和治疗药物的全球市场：性别歧视

  • 市场快照
  • 猴痘疫苗和疗法的全球市场：性别、性能和潜力分析
  • 全球猴痘疫苗和疗法市场，按性别估计和预测 (2019-2029)
  • 猴痘疫苗和治疗市场，细分分析
    • 男性
    • 女士
    • 其他

8 全球猴痘疫苗和疗法市场，按给药途径

  • 市场快照
  • 全球猴痘疫苗和治疗市场：按给药途径、性能-潜力分析
  • 2019-2029 年全球猴痘疫苗和疗法市场、按给药途径估计和预测
  • 猴痘疫苗和治疗市场，细分分析
    • 口服剂
    • 注射

9 全球猴痘疫苗和治疗市场，按最终用户分类

  • 市场快照
  • 猴痘疫苗和疗法的全球市场：最终用途的性能和潜力分析
  • 全球猴痘疫苗和疗法市场，按最终用途估计和预测 2019-2029
  • 猴痘疫苗和治疗市场，细分分析
    • 医院
    • 专科诊所
    • 其他

10 全球猴痘疫苗和治疗市场：区域分析

  • 猴痘疫苗和治疗市场：按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年各产品的估计和预测
      • 2019-2029 年按性别分类的估计和预测
      • 最终用户的估计和预测，2019-2029
    • 加拿大
  • 欧洲猴痘疫苗和治疗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区猴痘疫苗和治疗药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲猴痘疫苗和治疗药物市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 11 章 竞争信息

  • 顶级市场战略
  • 公司简介
    • Bavarian Nordic
      • 主要信息
      • 概述
      • 财务信息（视数据可用性而定）
      • 产品概要
      • 最近的发展
    • SIGA Technologies
    • Chimerix
    • Emergent
    • Gilead Sciences, Inc.
    • Sanofi SA
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • Reliance Life Sciences
    • Haffkine Institute

第十二章调查过程

  • 调查过程
    • 数据挖掘
    • 分析
    • 市场估计
    • 验证
    • 出版物
  • 调查属性
  • 调查先决条件

Global Monkeypox Vaccine and Treatment Market is valued at approximately USD 78.34 million in 2021 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2022-2029. The monkeypox virus, a species of the Orthopoxviral genus in the family Poxviridae, is the culprit behind monkeypox. The monkeypox vaccines employed in the smallpox eradication operation also offered protection from that disease. The Monkeypox Vaccine and Treatment market is expanding because of factors such an as Increase in the prevalence of monkeypox infection, and high government initiatives to combat outbreaks of monkeypox. However, Side effects associated with the vaccine and treatment may halt market growth.

For instance, according to information from the Centers for Disease Control and Prevention, there are estimated to be 31,800 confirmed cases of monkeypox worldwide through August 9, 2022, of which 31,425 are in nations that have never previously reported monkeypox. While there are 375 nations where monkeypox has previously been documented. Additionally, it was discovered that between April and June 2022, 98% of the monkeypox infections in 16 nations worldwide were in males who have sex with men and LGBT groups, per a report published in the New England Journal of Medicine. Thus, the rising prevalence of monkey pox disease across the globe is catering for the growth of the market. Furthermore, rising technological advancement in the development of vaccines and rising government initiatives for research and activities are creating lucrative growth in the market. However, the side effects of the Monkeypox Vaccine and Treatment stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monkeypox Vaccine and Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Among these regions, North America holds the highest share in the year 2021 owing to factors such as the rising prevalence of disease, and rising government investment in research and development is anticipated to provide lucrative growth in the market. Asia Pacific is projected to witness the fastest region owing to factors such as rising number of monkeypox infections and increasing research and development for developing vaccines driving the growth of market.

Major market players included in this report are:

Bavarian Nordic

SIGA Technologies

Chimerix Inc

Emergent

Gilead Sciences, Inc.

Sanofi SA

Emcure Pharma Company

Jinan Jinda Pharmaceutical Chemistry Co., Ltd

Reliance Life Sciences

Haffkine Institute for training research and testing

Recent Developments in the Market:

  • In February 2022, Bavarian Nordic A/S announced the contract of 2.5 million doses of an additional order of JYNNEOS from the U.S.
  • In Aug 2022, the tecovirimat (oral) by SIGA was licenced by the U.K. for the management of monkeypox and other indications in adults and children with body weights greater than 13 kg. The medication has also been given the go-ahead to treat monkeypox sickness in other European nations.

Global Monkeypox Vaccine and Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Gender, Route of Administration, End Use, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Vaccine

Drugs

Vaccinia Immune Globulin (VIG)

By Gender:

Male

Female

Others

Route of Administration:

Oral

Injectables

By End Use:

Hospitals

Specialty ClinicsOthers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Monkeypox Vaccine and Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Monkeypox Vaccine and Treatment Market, by Product, 2019-2029 (USD Million)
    • 1.2.3. Monkeypox Vaccine and Treatment Market, by Gender, 2019-2029 (USD Million)
    • 1.2.4. Monkeypox Vaccine and Treatment Market, by Route of Administration, 2019-2029 (USD Million)
    • 1.2.5. Monkeypox Vaccine and Treatment Market, by End Use, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Monkeypox Vaccine and Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Monkeypox Vaccine and Treatment Market Dynamics

  • 3.1. Monkeypox Vaccine and Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence and prevalence of Monkeypox
      • 3.1.1.2. Government initiatives to combat an outbreak of monkeypox
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with the vaccine and treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in vaccine development activities

Chapter 4. Global Monkeypox Vaccine and Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Monkeypox Vaccine and Treatment Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Monkeypox Vaccine and Treatment Market by Product, Performance - Potential Analysis
  • 6.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 6.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 6.4.1. Vaccine
    • 6.4.2. Drugs
    • 6.4.3. Vaccinia Immune Globulin (VIG)

Chapter 7. Global Monkeypox Vaccine and Treatment Market, by Gender

  • 7.1. Market Snapshot
  • 7.2. Global Monkeypox Vaccine and Treatment Market by Gender, Performance - Potential Analysis
  • 7.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Gender 2019-2029 (USD Million)
  • 7.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 7.4.1. Male
    • 7.4.2. Female
    • 7.4.3. Others

Chapter 8. Global Monkeypox Vaccine and Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Monkeypox Vaccine and Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
  • 8.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectables

Chapter 9. Global Monkeypox Vaccine and Treatment Market, by End Use

  • 9.1. Market Snapshot
  • 9.2. Global Monkeypox Vaccine and Treatment Market by End Use, Performance - Potential Analysis
  • 9.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
  • 9.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Others

Chapter 10. Global Monkeypox Vaccine and Treatment Market, Regional Analysis

  • 10.1. Monkeypox Vaccine and Treatment Market, Regional Market Snapshot
  • 10.2. North America Monkeypox Vaccine and Treatment Market
    • 10.2.1. U.S. Monkeypox Vaccine and Treatment Market
      • 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. ijkl breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Monkeypox Vaccine and Treatment Market
  • 10.3. Europe Monkeypox Vaccine and Treatment Market Snapshot
    • 10.3.1. U.K. Monkeypox Vaccine and Treatment Market
    • 10.3.2. Germany Monkeypox Vaccine and Treatment Market
    • 10.3.3. France Monkeypox Vaccine and Treatment Market
    • 10.3.4. Spain Monkeypox Vaccine and Treatment Market
    • 10.3.5. Italy Monkeypox Vaccine and Treatment Market
    • 10.3.6. Rest of Europe Monkeypox Vaccine and Treatment Market
  • 10.4. Asia-Pacific Monkeypox Vaccine and Treatment Market Snapshot
    • 10.4.1. China Monkeypox Vaccine and Treatment Market
    • 10.4.2. India Monkeypox Vaccine and Treatment Market
    • 10.4.3. Japan Monkeypox Vaccine and Treatment Market
    • 10.4.4. Australia Monkeypox Vaccine and Treatment Market
    • 10.4.5. South Korea Monkeypox Vaccine and Treatment Market
    • 10.4.6. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market
  • 10.5. Latin America Monkeypox Vaccine and Treatment Market Snapshot
    • 10.5.1. Brazil Monkeypox Vaccine and Treatment Market
    • 10.5.2. Mexico Monkeypox Vaccine and Treatment Market
  • 10.6. Rest of The World Monkeypox Vaccine and Treatment Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Bavarian Nordic
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. SIGA Technologies
    • 11.2.3. Chimerix
    • 11.2.4. Emergent
    • 11.2.5. Gilead Sciences, Inc.
    • 11.2.6. Sanofi SA
    • 11.2.7. Emcure Pharma
    • 11.2.8. Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • 11.2.9. Reliance Life Sciences
    • 11.2.10. Haffkine Institute

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Monkeypox Vaccine and Treatment Market, report scope
  • TABLE 2. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 4. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Gender 2019-2029 (USD Million)
  • TABLE 5. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
  • TABLE 6. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by End Use 2019-2029 (USD Million)
  • TABLE 7. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 69. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 71. List of secondary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 72. List of primary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Monkeypox Vaccine and Treatment Market, research methodology
  • FIG 2. Global Monkeypox Vaccine and Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Monkeypox Vaccine and Treatment Market, key trends 2021
  • FIG 5. Global Monkeypox Vaccine and Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Monkeypox Vaccine and Treatment Market, porters 5 force model
  • FIG 7. Global Monkeypox Vaccine and Treatment Market, pest analysis
  • FIG 8. Global Monkeypox Vaccine and Treatment Market, value chain analysis
  • FIG 9. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Monkeypox Vaccine and Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Monkeypox Vaccine and Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable